Mind Bending Experience: Clinical Applications and Legal Considerations of Neuroactive FDA Scheduled Medications

Mental health disorders have been increasingly recognized and diagnosed over the past several years. FDA approved medications serve as a cornerstone in treatment but are not effective for all patients. Research is emerging to support the use of psychoactive medications for the treatment of various mental health disorders. As these medications have been previously considered to be ‘psychedelics’ and recreational and carry a stigma associated with their use, some practitioners may be uncomfortable with use of these agents in practice. Further complicating utilization, more specifically with cannabinoid use (products containing THC and/or CBD in various concentrations and dosage forms), the legal landscape remains problematic in select scenarios and states. Practitioners grapple with the use of these new, and at times unregulated, products obtained from local dispensaries vs FDA approved agents. Non-FDA approved options may lack quality controls, information on contents, and represent a need for consistency. The goal of this program is to review the evidence, therapeutics, and legislative changes underway for the use of psychoactive agents (i.e. esketamine, psilocybin, MDMA and cannabinoids) for use in various health conditions to better equip pharmacists to comprehensively address the use of these agents within their practice.

Moderator: Brent A. Hall, Pharm.D., BCPPS Pharmacy Specialist, Pediatrics Pediatrics PGY2 Residency Director Associate Clinical Professor, UCSF School of Pharmacy UC Davis Children's Hospital, UC Davis Medical Center Sacramento, CA   View Biography

The Medical Magic of Psychoactive Agents 9:45 AM to 10:15 AM Speaker: Jeremy Daniel, Pharm.D., BCPP, BCPS Psychiatric Clinical Pharmacist, Avera Behavioral Health Center Associate Professor, Pharmacy Practice South Dakota State University Sioux Falls, SD    View Biography

Cannabis Goes Mainstream: Lessons Learned 10:15 AM to 10:45 AM Speaker: Lisa M. Holle, Pharm.D., B.S.Pharm, BCOP Clinical Professor University of Connecticut School of Pharmacy Storrs, CT   View Biography

Safely Navigating the Medical Legal Issues Associated with Patient Use of Non-federally Approved Drugs 10:45 AM to 11:15 AM Speaker: Ann M. Philbrick, Pharm.D., FCCP, BCACP Associate Professor Department of Pharmaceutical Care and Health Systems & Department of Family Medicine and Community Health University of Minnesota Minneapolis, MN   View Biography